EMILY MILLER: Open Payments
NPI 1841972825 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 30 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $480 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $81 |
| ABBVIE INC. | 5 | $76 |
| Teva Pharmaceuticals USA, Inc. | 4 | $74 |
| E.R. Squibb & Sons, L.L.C. | 3 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| HARMONY BIOSCIENCES LLC | 2 | $35 |
| Alkermes, Inc. | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| LivaNova USA, Inc. | 1 | $20 |
| ACADIA Pharmaceuticals Inc | 1 | $18 |
Products named: VRAYLAR, Sunosi, COBENFY, REXULTI, AUSTEDO XR, Auvelity, UZEDY, WAKIX.
Industry payments across IA — which companies pay providers there.
